Tamara McGrillen | Head, Investor Relations |
Geert Cauwenbergh | President and Chief Executive Officer |
Gerrit Dispersyn | Chief Development Officer |
Caitlin Kontulis | Principal Accounting Officer |
John Vandermosten | Zacks Small Cap |
Steven Zelcer | Private Investor |
Michael May | Shareholder |
Lawrence Kate | Private Investor |
Good day, ladies and gentlemen and welcome to today’s webcast entitled RXi Pharmaceutical First Quarter 2018 Conference Call. Today’s call is being recorded. At this time, it is my pleasure to turn the floor over to Head of Investor Relations for RXi, Ms. Tamara McGrillen. Ma’am, the floor is yours.